#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16180	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2124	756.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	991	C,T	918,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29048	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3605	804.0	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	902	C,T,A	844,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29048	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3605	804.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1684	1684	A	882	A	838	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29048	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3605	804.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	945	C,G	861,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29048	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3605	804.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	977	A	916	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29048	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3605	804.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	917	C	860	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2096	folP	852	852	100.0	folP.l15.c30.ctg.1	1606	129.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1092	1094	AGC	193;193;194	A;G;C	177;178;179	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3336	163.9	1	SNP	p	S91F	0	.	.	271	273	TCC	577	579	TCC	182;182;183	T;C,T;C	167;167,1;166	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3336	163.9	1	SNP	p	D95N	0	.	.	283	285	GAC	589	591	GAC	165;165;169	G;A,G;C	154;156,1;159	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3336	163.9	1	SNP	p	D95G	0	.	.	283	285	GAC	589	591	GAC	165;165;169	G;A,G;C	154;156,1;159	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1648	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1424	115.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	452	454	ACC	203;200;200	A,G;C;C	180,1;186;186	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1648	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1424	115.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	467	469	CAC	180;182;184	C;A,G;C	169;166,1;173	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1648	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1424	115.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	650	652	CAC	181;179;180	C,T;A;C,T	166,1;166;168,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1648	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1424	115.2	1	SNP	p	G45D	0	.	.	133	135	GGC	470	472	GGC	188;194;196	G;G;C	176;180;182	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	964	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	900	106.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5522	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2973	185.2	1	SNP	p	D86N	0	.	.	256	258	GAC	622	624	GAC	227;224;224	G;A;C	205;202;202	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5522	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2973	185.2	1	SNP	p	S87W	0	.	.	259	261	AGT	625	627	AGT	225;227;225	A;G;T	204;208;202	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5522	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2973	185.2	1	SNP	p	S87R	0	.	.	259	261	AGT	625	627	AGT	225;227;225	A;G;T	204;208;202	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5522	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2973	185.2	1	SNP	p	S87I	0	.	.	259	261	AGT	625	627	AGT	225;227;225	A;G;T	204;208;202	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5522	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2973	185.2	1	SNP	p	S88P	0	.	.	262	264	TCC	628	630	TCC	224;227;230	T,C;C;C	204,1;206;210	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4372	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2598	167.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1563	1565	GGC	203;203;204	G;G;C	185;183;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1147	1149	GCA	257;255;256	G,A;C;A	232,1;229;235	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1150	1152	ATC	256;258;260	A;T;C	236;237;235	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1162	1164	GTG	248;249;247	G;T,A;G	230;230,1;232	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1162	1164	GTG	248;249;247	G;T,A;G	230;230,1;232	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1666	1668	ACC	159;158;156	A;C;C	146;149;147	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1720	1722	GCG	174;171;168	G;C,T,G;G	155;137,1,1;140	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1720	1722	GCG	174;171;168	G;C,T,G;G	155;137,1,1;140	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1843	1845	GGC	166;164;162	G,A;G;C	142,1;141;143	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1852	1854	GGC	153;151;153	G;G;C	133;129;133	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4362	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2179	197.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1870	1872	CCG	141;146;145	C,G;C,G;G,A	96,10;101,2;103,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6180	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3142	196.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2374	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1764	134.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	531	531	C	178	C	156	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	465	467	GGA	259;255;256	G;G,A;A	235;229,1;231	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	F135L	NONSYN	403	405	TTT	726	728	CTT	207;206;210	C;T;T,G	193;192;196,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	R143G	NONSYN	427	429	AGA	750	752	GGA	218;219;218	G;G;A	206;205;200	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	D171G	NONSYN	511	513	GAT	834	836	GGT	227;229;231	G;G;T	200;202;199	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	G189S	NONSYN	565	567	GGC	888	890	AGC	208;207;205	A;G;C	193;192;191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	G203V	NONSYN	607	609	GGC	930	932	GTC	184;186;189	G;T;C	170;174;176	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	954	954	T	178	T	169	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	1	SNP	p	G120K	0	.	.	358	360	GGT	681	683	GGT	235;235;236	G;G;T	223;223;217	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	1	SNP	p	A121N	0	.	.	361	363	GCC	684	686	GCC	233;233;235	G;C;C	220;223;223	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2880	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1511	189.0	1	SNP	p	A121D	0	.	.	361	363	GCC	684	686	GCC	233;233;235	G;C;C	220;223;223	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11090	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4891	226.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1955	1957	AAT	275;274;271	A;A;T	249;249;243	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1190	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1009	116.6	1	SNP	p	V57M	1	.	.	169	171	ATG	441	443	ATG	252;248;247	A;T;G	239;234;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
